Maxgrow India Ltd

Maxgrow India Ltd has announced that its Board of Directors will convene on July 31, 2026. The meeting's agenda includes the consideration and approval of the standalone and consolidated audited financial results for the quarter and year ended March 31, 2026, as well as the standalone and consolidated financial results for the quarter ended June 30, 2026, along with their limited review reports. Additionally, the board will discuss any other matters as deemed necessary. The company has also stated that the trading window for designated persons will remain closed until 48 hours after the financial results become generally available.

Maxgrow India Ltd has announced that its Board of Directors will convene on July 31, 2026. The meeting agenda includes the consideration and approval of the standalone and consolidated audited financial results for the quarter and year ended March 31, 2026, as well as the financial results for the quarter ended June 30, 2026, along with the limited review report. Additionally, the board will discuss other matters as they arise. The company has also stated that the trading window for designated persons will remain closed until 48 hours after the financial results become generally available.

Maxgrow India Ltd has announced that its Board of Directors will convene on July 31, 2026. The primary agenda items include the consideration and approval of standalone and consolidated audited financial results for the quarter and year ended March 31, 2026, and the standalone and consolidated financial results for the quarter ended June 30, 2026, along with their respective limited review reports. The company also noted that the trading window for designated persons will remain closed until 48 hours after the financial results become generally available.

Maxgrow India Ltd announced the appointment of Mr. Santosh G. Doke as its new Chief Financial Officer (CFO), effective July 24, 2026. The decision was made by the Board of Directors following recommendations from the Nomination and Remuneration Committee & Audit Committee. Mr. Doke brings 14 years of experience in Accounts and Finance, having worked with various companies. This appointment is in compliance with the Companies Act, 2013, and SEBI Listing Regulations.

Maxgrow India Ltd announced the appointment of Mr. Santosh G. Doke as the new Chief Financial Officer (CFO) of the company. The appointment was approved by the Board of Directors at a meeting held on July 24, 2026, following recommendations from the Nomination and Remuneration Committee and the Audit Committee. Mr. Doke brings 14 years of experience in Accounts and Finance. His term as CFO is effective from July 24, 2026, and will continue until his resignation or cessation.

Maxgrow India Ltd announced that its Board of Directors, in a meeting held on June 29, 2026, approved the appointment of M/s. V. G. Kamat & Associates as Internal Auditor for FY 2026-27. The Board also appointed Dr. M Krishnan as an Additional Non-Executive Independent Director, effective the same date, for a term of five years, subject to shareholder approval. Dr. Krishnan brings 37 years of experience in banking and corporate finance. The company also confirmed that Dr. Krishnan is not related to any existing director on the board.

Maxgrow India Ltd announced key board decisions made on June 29, 2026. The company appointed M/s. V. G. Kamat & Associates as its Internal Auditor for the Financial Year 2026-27. Additionally, Dr. M Krishnan was appointed as an Additional Director under the category of Non-Executive Independent Director, effective the same date. Dr. Krishnan brings 37 years of experience in banking and corporate roles. His appointment is subject to shareholder approval. The company also confirmed Dr. Krishnan is not debarred from directorship.

Maxgrow India Ltd announced key appointments following a Board of Directors meeting on June 29, 2026. The company has appointed M/s. V. G. Kamat & Associates as its Internal Auditor for the Financial Year 2026-27. Additionally, Dr. M Krishnan has been appointed as an Additional Non-Executive Independent Director, effective the same date, for a term of five years, subject to shareholder approval. Dr. Krishnan brings 37 years of extensive experience in Indian and international banking.

Maxgrow India Ltd has announced the closure of its trading window for all designated persons. This closure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal code of conduct. The window will remain shut from July 01, 2026, and will reopen 48 hours after the financial results for the quarter and year ended March 31, 2026, and for the quarter ended June 30, 2026, are made public. Designated persons and their immediate relatives are prohibited from trading in the company's securities during this period.

Maxgrow India Ltd has announced a further extension for the submission of its Audited Financial Results for the quarter and financial year ended March 31, 2026. The company cited pending financial statements and audit-related matters as reasons for the delay, which are attributed to unavoidable circumstances beyond its control. Maxgrow India, along with its statutory auditors, is working to finalize the results and expects to submit them by June 30, 2026. The trading window for designated persons will remain closed until 48 hours after the declaration of these results.